Cargando…

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma

BACKGROUND: Cystatins are a class of proteins that can inhibit cysteine protease and are widely distributed in human bodily fluids and secretions. Cystatin SN (CST1), a member of the CST superfamily, is abnormally expressed in a variety of tumors. However, its effect on the occurrence and developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jian, Luo, Gaomeng, Li, Chang, Zhao, Zhunlin, Ju, Sheng, Li, Qifan, Chen, Zhike, Ding, Cheng, Tong, Xin, Zhao, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150371/ https://www.ncbi.nlm.nih.gov/pubmed/35637432 http://dx.doi.org/10.1186/s12885-022-09685-z

Ejemplares similares

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
por: Cui, Yuan, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition
por: Chao, Yin-Kai, et al.
Publicado: (2016)

Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer
por: Li, Taiyuan, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)

Research progress of cystatin SN in cancer
por: Liu, Yanfang, et al.
Publicado: (2019)

Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity
por: Kim, J-T, et al.
Publicado: (2013)

TCTP promotes epithelial–mesenchymal transition in lung adenocarcinoma
por: Sun, Ruilin, et al.
Publicado: (2019)

Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer
por: Ma, Yunxia, et al.
Publicado: (2017)

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016)

Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
por: Zhao, Zhongquan, et al.
Publicado: (2014)

lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent Epithelial–Mesenchymal Transition
por: Min, Weili, et al.
Publicado: (2022)

Cystatin C and Cystatin SN As Possible Soluble Tumor Markers in Malignant Uveal Melanoma
por: Dikovskaya, Maria A., et al.
Publicado: (2021)

The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β
por: Sokol, Jonathan P, et al.
Publicado: (2005)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Cystatin SN Upregulation in Patients with Seasonal Allergic Rhinitis
por: Imoto, Yoshimasa, et al.
Publicado: (2013)

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients
por: Schrader, Carola H., et al.
Publicado: (2015)

Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
por: Chen, Xiaosu, et al.
Publicado: (2021)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021)

Dusp6 Inhibits Epithelial-mesenchymal Transition in Endometrial Adenocarcinoma Via ERK Signaling Pathway
por: Fan, Ming-Jun, et al.
Publicado: (2019)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma
por: Li, Dandan, et al.
Publicado: (2021)

RFC3 induces epithelial-mesenchymal transition in lung adenocarcinoma cells through the Wnt/β-catenin pathway and possesses prognostic value in lung adenocarcinoma
por: Gong, Shulei, et al.
Publicado: (2019)

The prognostic value of Tiam1 correlates with its roles in epithelial–mesenchymal transition progression and angiogenesis in lung adenocarcinoma
por: Zhu, Guang, et al.
Publicado: (2019)

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma
por: Matsubara, Taichi, et al.
Publicado: (2019)

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Collagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma Cells
por: Clementz, Anthony G., et al.
Publicado: (2013)

Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
por: Wang, Lei, et al.
Publicado: (2017)

The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion
por: Yang, Jian, et al.
Publicado: (2023)

The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma
por: Zhou, Jiahui, et al.
Publicado: (2023)

LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma
por: Hou, Xiao-ming, et al.
Publicado: (2019)

SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Zhao, Jinming, et al.
Publicado: (2020)

Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
por: Chen, You-Fang, et al.
Publicado: (2013)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hq98rkj9vk1b45seaqhp65ksf8